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Prognosis of adult onset polycystic kidney disease re-evaluated. To ap-
praise the prognosis of adult onset polycystic kidney disease (APKD),
an inception cohort containing 140 subjects from 17 kindreds was as-
sembled. Multiple renal cysts, demonstrable by ultrasonography, or
clinical APKD, or both were present in 100 subjects. APKD was pre-
dicted in 32 subjects unavailable for ultrasonography and could not be
excluded in eight deceased subjects. All had been at risk for endstage
renal disease (ESRD) since birth. The probability of either developing
ESRD, requiring dialysis or transplantation, or dying was estimated
using a time-to-event analysis. The earliest age at which ESRD oc-
curred was 36 years. For those with APKD, the probability of being
alive and not having ESRD was 77% by age 50, 57% by age 58, and
52% by age 73 years. Excluding those predicted to have APKD
changes these probabilities to 75, 53, and 47%, respectively. The se-
rum creatinine values were less than 1.5 mg/dl for most subjects who
had not developed ESRD. The prognosis for subjects with APKD is
much better than most reports suggest and can be estimated from the
time-to-event data presented.
Pronostic de Ia maladie debut polykystose rénale de l'adulte évalué de
nouveau. Afin d'apprécier le pronostic de Ia polykystose rénale de
l'adulte (APKD), un ensemble de 140 sujets provenant de 17 familIes a
été assemble. Des kystes rénaux multiples démontrés echographique-
ment, une APKD clinique ou les deux existaient chez 100 sujets.
L'APKD a été prédite chez 32 sujets inaptes pour l'Cchographie et n'a
Pu être exclue chez huit sujets décédés. Tous ont etC soumis au risque
d'insuffisance rCnale terminale (ESRD) depuis leur naissance. La
probabilite de développer une ESRD nécessitant. Ia dialyse ou Ia trans-
plantation, ou de mourir a etC estimCe en utilisant une analyse temps-
évCnement. L'hge Ic plus jeune auquel est survenu une ESRD était de
36 ans. Pour ceux atteints d'APKD, Ia probabilité d'être en vie sans
ESRD était de 77% a 50 ans, 57% a 58 ans. et 52% a 73 ans. En exclu-
ant ceux chez qui I'APKD était vraisemblable ces probabilites Ctaient
de 75, 53, et 47%, respectivement. Les valeurs de créatininémie étaient
infCrieures a 1,5 mg/dl chez Ia plupart des sujets n'ayant pas developpe
d'ESRD. Le pr000stic des malades atteints d'APKD est bien meilleur
que ne Ic suggère Ia plupart des articles, et peut étre estimé a partir
des données en temps-Cvénement présentCes.
Adult onset polycystic kidney disease (APKD) is a disorder
of autosomal dominant inheritance, with essentially complete
penetrance but variable expressivity or clinical presentation. It
is now well established that a long asymptomatic period may
preceed clinical onset, during which cysts are demonstrated
with ultrasonography.
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Data regarding prognosis for patients with APKD are in-
consistent. In three studies, mean life expectancy following
clinical presentation ranged from 4 to 13 years [1—3], being con-
siderably shorter for patients older than 50 years at the time of
presentation [31. These studies were reported in 1933 [1], 1949
[2], and 1957 [3]; their findings may not be applicable now. A
more recent report [4] estimates that 70% of patients with
APKD will develop endstage renal disease (ESRD) if they sur-
vive to age 65. On the other hand, Hatfield and Pfister [51 found
that 32 of 58 patients with APKD (50 confirmed at autopsy) had
no recorded symptoms of this disease. The average age of
death for the symptomatic patients was 51.8 years as com-
pared to 73.0 years for those without symptoms. They sug-
gested that many persons with APKD remain asymptomatic
and have a normal lifespan [51.
In this context, the prognosis of asymptomatic patients
whose APKD is diagnosed in the course of investigation (for
example, for genetic counseling) is of obvious interest. We
have studied 17 APKD kindreds and report the prognosis for
affected members.
Methods
Index cases were ascertained by survey of all nephrologists
and urologists in the Province of Newfoundland and Labrador,
Canada. Pedigrees were constructed and individuals thought to
have APKD were tentatively identified. The diagnosis was con-
sidered confirmed if any of the following had been docu-
mented: (1) autopsy reporting APKD, (2) death from chronic
renal failure with a clinical diagnosis of APKD, (3) surgical re-
port indicating APKD, (4) excretory urographic diagnosis of
APKD on review of original films, and (5) unequivocal diag-
nosis by gray-scale ultrasonography. An attempt was made to
contact all previously unstudied members of the kindreds who
resided in Newfoundland and Labrador and who were at risk
by reason of having an affected parent, sibling, or child.
These previously unstudied persons were offered ultrasonog-
raphy. Those who accepted had sonographic scans of the kid-
neys in saggital and transverse planes, using either the ADR
Ultrasound Real-time Scanner (model 2130, ADR Ultrasound,
Tempe, Arizona) or the Picker Echo Dynamic Control Scan-
ner and Picker 80 Linagraph Digital Imager (Picker Corp.,
Cleveland, Ohio). All scans were performed under the super-
vision of one ultrasonographer and interpreted by one radiolo-
gist without knowledge of the clinical status. APKD was con-
sidered present if at least three cysts were present in each kid-
ney. If the findings suggested cystic disease but the diagnostic
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criteria were not met, the examination was designated
equivocal.
Serum creatinine was measured using a standard technicon
Auto-Analyzer technique (Technicon Corp., Tarrytown, New
York). Blood pressure (BP) was determined in the supine po-
sition after 3 mm rest with the fifth Korotkoff sound recorded
as diastolic pressure. Hypertension was defined as a fifth Ko-
rotkoff sound greater than 90 mm Hg. A midstream urine sam-
ple was obtained for culture.
A study of prognosis for a particular disorder requires that a
group of subjects be followed from an early and uniform stage
of the disorder. The term "inception cohort" has been used to
describe such a group [6]. The primary outcome of interest is
ESRD and each kindred member with APKD had been at risk
for this outcome since birth. The time of follow-up is the age
of the subject. ESRD is defined as renal failure requiring ei-
ther dialysis or transplantation. The Kaplan-Meier [71 estimate
of survival to ESRD was used.
To avoid an ascertainment bias, index cases were excluded
from the analysis. Three groups presented methodologic prob-
lems: subjects who had died prior to the study, those who re-
fused the study, and those who were unavailable by reason of
migration from the Province.
Failure to consider those who died introduces a prevalence-
incidence bias [8] wherein those who had died from ESRD
would not be counted as an event. For those deceased sub-
jects who had a clinical diagnosis of APKD, death was counted
as an ESRD event. For those deceased subjects for whom
there was no history of APKD, follow-up was censored at the
time of death. The subjects who refused study may have in-
cluded some with APKD. None had ESRD. By counting
APKD deaths as an ESRD event and by excluding those who
refused study, the prognosis should be biased toward a worse
outcome.
Failure to include persons who had left the study area would
bias the analysis as some presumably carry the APKD allele.
It was assumed that among those persons unavailable for the
study, the proportion with cysts detectable by ultrasonogra-
phy would not be different from that among those studied. The
number expected to have cysts was, therefore, calculated from
findings in the persons studied and added to the number ob-
served, taking account of their ages. It seemed reasonable to
assume that none in this group would have died or required
dialysis or transplantation without the knowledge of family in-
formants. As migrants tend to be healthier than the general
population, it is possible that these assumptions are incorrect.
If true, there would be a bias toward a more favorable out-
come. The results are therefore reported both using these as-
sumptions and excluding those who had migrated.
Results
The 17 kindreds contained 313 individuals excluding index
cases. Their age distribution and APKD status are shown in
Table 1. Twenty-seven had previously diagnosed APKD, 174
submitted to ultrasound examination, 17 refused, and 95 were
unavailable for the study due to absence from the study area.
The four subjects with an equivocal ultrasound examination
had no evidence of cysts on excretory urography with nephro-
tomography. Sixty persons were newly diagnosed in the course
of the ultrasonography study. Twenty-one persons were de-
Table 1. Age group distribution of living kindred members and APKD
status
APKD Ultra- Ultra- Not
by sound sound available
Known ultra- nega- equiv- for Re-
Age APKD sound tive ocal study fused Total
Oto9 0 2 16 0 15 0 33
10 to 19 0 14 27 1 17 0 59
20 to 29 3 27 35 2 32 4 103
30to39 8 5 15 0 19 3 50
40to49 7 4 4 0 6 2 23
50to59 5 7 6 0 3 4 25
60 4 1 7 1 3 4 20
27 60 110 4 95 17 313
Table 2. Inception cohort: age group distribution and source of APKD
diagnosis
Deceased- Deceased- Liv- Ultra- Ultra-
clinical no clinical ing- sound sound
Age diagnosis diagnosis known posi- positive Total
years APKD APKDAPKD tive predicted APKD
Oto9 0 0 0 2 2 4
lOtol9 0 0 0 14 6 20
20to29 0 0 3 27 14 44
30to39 0 2 8 5 5 20
40to49 9 3 7 4 3 26
50to59 4 I 5 7 1 18
60 0 2 4 1 1 8
13 8 27 60 32 140
Ultrasound positive (predicted) equals the number unavailable for
study in each age group multiplied by the proportion positive among
those studied by ultrasound in that age group.
ceased at the time of the study, thirteen with a clinical diag-
nosis of APKD (age range, 40 to 56 years). The composition of
the inception cohort, excluding index cases, is shown in Table
2. These 140 subjects had been at risk for ESRD since birth,
and the period of follow-up for each is their age at the time of
the study or at the occurrence of ESRD or death. Included
among these 140 subjects are 32 subjects predicted to have
APKD and eight deceased subjects in whom APKD could not
be excluded. Table 3 and Figure 1 show the cumulative occur-
rence of ESRD in this cohort. The youngest subject in whom
endstage renal failure occurred was 36 years old. The probabil-
ity of a person with APKD remaining alive and not requiring
either dialysis or transplantation was 77% by age 50, 57% by
age 58, and 52% by age 73 years. There was no difference be-
tween the time-to-event curves for males and females.
Table 4 shows the cumulative occurrence of ESRD in the co-
hort excluding those who were unavailable for the study due
to migration. The probability of a person with APKD remain-
ing alive and not requiring either dialysis or transplantation was
75% by age 50, 53% by age 58, and 47% by age 73 years.
Serum creatinine values for subjects not requiring dialysis or
transplantation exceeded 1.5 mg/dl in 0 of 40 aged less than 30
years, 4 of 22 aged 30 to 49 years and 3 of 13 aged greater than
49 years. Urine cultures were obtained from 39 subjects; only
two had a significant bacterial growth (> 100,000 colonies/mI).
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Abbreviations: N, number of subjects alive without ESRD at the
beginning of the j'' interval; o, number of subjects who died or
developed ESRD during the interval; X, number of subjects who
were lost or censored during the jth interval; P3, estimate for P3 the
probability of surviving the j"' interval without developing ESRD given
that the subject has survived the previous intervals; P,, estimated
survival (time-to-event) curve.
The 140 subjects are 100 with documented APKD plus 32 predicted
APKD and 8 who had died before the study but for whom APKD status
was uncertain.
' SE of P(t) is represented by the values in this column.
Hypertension was diagnosed in 21 of 52 subjects (40%) who did
not have ESRD.
Discussion
These results suggest that the prognosis for persons with
APKD is not as grim as reported previously [1—3], due primar-
ily to the inclusion in this study of asymptomatic as well as
symptomatic persons. The subjects studied by previous inves-
tigators [1—31 had developed symptoms (either pain, palpable
mass, or uremia) and were, with few exceptions, ascertained
either through admission to a hospital for investigation, or at
autopsy. Affected but asymptomatic persons generally would
not have been detected. Death was due to uremia in 59% while
cerebral hemorrhage and heart failure were responsible for half
of the remaining deaths [3]. Less effective medical treatment of
co-morbid conditions probably contributed to the poor prog-
nosis in early studies [1—31. A more recent report [4] indicating
that 70% of patients presenting to a referral center develop
ESRD by age 65 years may be subject to a "referral filter"
bias, meaning that referral centers tend to attract patients with
more serious medical problems who are not representative of
all patients [8]. Our findings are more consistent with those in
the series reported by Hatfield and Pfister [5] in which 55% of
the patients had no recorded symptoms.
A formal study of prognosis requires clear description of the
inception cohort and referral pattern, and at least an 80% fol-
low-up [6]. These methodologic criteria give some confidence
as to the representativeness of the material. In addition, ob-
jective outcome criteria, "blind" assessment and adjustment
for extraneous prognostic factors are required to minimize bias
[61. In our inception cohort, all subjects had either docu-
mented or predicted APKD and therefore had been at risk for
80 the outcome (ESRD) since birth. Some persons with the APKD
allele but not demonstrating ultrasound or clinical manifesta-
tions presumably could have been excluded from the inception
cohort. As the majority of subjects so excluded would have
been aged less than 30 years [9], this should not appreciably
bias the analysis presented.
We had assumed that a proportion of those unavailable for
the study had asymptornatic APKD and adjusted the number
at risk to account for this. Only eight of the 32 subjects so
added were older than age 36 (the age of the first event) and
would therefore have little impact on the time-to-event curve.
Comparison of the time-to-event data in Tables 3 (including
predicted APKD) and 4 (excluding predicted APKD) shows
change in the estimate of 2% by age 50, 4% by age 58, and 5%
by age 73 years. The SE increased by virtue of the decrease in
number of subjects in each interval. The inclusion of all APKD
deaths as ESRD events and exclusion of those who had re-
fused study biased the prognosis adversely. Despite these bi-
ases, the prognosis appears much better than in previous re-
ports except that of Hatfield and Pfister [5].
Ascertainment was neither complete nor random. Persons
with APKD who are known to urologists and nephrologists are
Table 3. Time-to-event table for 140 subjects' at risk for ESRD Table 4. Time-to-event table for 108 subjectsa at risk for ESRD
Inter- Time Inter- Time
Inter- val of Inter- val of
val number event N 0) A3 P3 P, SE" val number event 1 0) X f f), SE"
[36,40) 1 36 59 1 6 0.983 0.983 0.017 [36,40) 1 36 51 1 3 0.980 0.980 0.019
[40,41) 2 40 52 3 0 0.942 0.926 0.017 [40,41) 2 40 47 3 0 0.936 0.918 0.039
[41,42) 3 41 49 1 1 0.979 0.907 0.025 141,42) 3 41 44 1 1 0.977 0.897 0.044
[42,43) 4 42 47 2 5 0.957 0.868 0.030 [42,43) 4 42 42 2 5 0.952 0.854 0.051
[43,46) 5 43 40 1 2 0.975 0.846 0.036 [43,46) 5 43 35 1 1 0.971 0.830 0.055
[46,47) 6 46 37 I 4 0.973 0.823 0.042 [46,47) 6 46 33 I 3 0.970 0.805 0.059
[47,48) 7 47 32 1 0 0.969 0.798 0.048 [47,48) 7 47 29 I 0 0.966 0.777 0.063
[48,50) 8 48 31 1 4 0.967 0,771 0.053 [48,50) 8 48 28 1 3 0.964 0.749 0.067
[50,54) 9 50 26 I 6 0.962 0.742 0.058 [50,54) 9 50 24 1 7 0.958 0.718 0.071
[54,56) 10 54 19 1 2 0.947 0.703 0.067 [54,56) 10 54 16 I 1 0.938 0.673 0.080
[56,58) 11 56 16 3 2 0.813 0.571 0.067 [56,58) 11 56 14 3 2 0.786 0.529 0.097
[58,73) 12 58 11 1 10 0.909 0.519 0.079 [58,73) 12 58 9 I 8 0.889 0.470 0.102
Abbreviations arc the same as those used for Table 3.
a The 108 subjects are 100 with documented APKD described in the
text plus 8 who had died before the study but for whom APKD status
was unknown.
SE of P(t).
j 40
20
10 20 30 40 50 60 70
Age, years
Fig. 1. Survival or time-to-event curve showing the probability of re-
maining alive without ESRD based on outcomei observed in 140 per-
sons with APKD (documented and predicted).
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likely to have more serious diseases than those who are not.
Many already had ESRD, the outcome of interest. To de-
crease this ascertainment bias, the index cases were excluded.
The possibility that affected relatives of these index cases have
a more severe form of the disease than others with APKD can-
not be excluded. The outcome measure, ESRD, is objective
and can be evaluated without "blinding." It seemed reason-
able to assume that no family member would have required
dialysis or transplantation, or died, unknown to family
informants.
To the extent that the subjects studied are representative of
all patients with APKD and the outcome measure valid, esti-
mates of the probability of developing endstage renal disease
or a fatal complication of the disorder can be given (Table 3,
Fig. 1).
For those who have not developed ESRD, few have clini-
cally significant impairment of creatinine clearance, and this is
true even for those aged more than 50 years, for whom serum
creatinine values were less than 1.5 mg/dl in 10 of 13 tested.
We have not attempted to adjust for extraneous prognostic
factors because data on these are incomplete. Urinary tract in-
fection and hypertension have been implicated as important
prognostic factors. Urinary tract infection was present at the
time of study in only 2 of 39 persons while hypertension was
present in 17 of 30 subjects over the age of 30, none of whom
were on dialysis. Whether hypertension accelerates the rate of
deterioration or whether treatment will prevent it cannot be an-
swered from this study.
A logical extension of this investigation would be to evalu-
ate the effect that factors such as sex, inheritance from mother
or father, kidney size, cyst number or size or both, hyper-
tension, urinary tract infection, hernaturia, and hyperuricemia
have on the probability of developing ESRD. Cox [101 has pro-
posed a regression model which allows for analysis of cen-
sored survival or time-to-event data adjusting for continuous as
well as discrete co-variates. Application of this model to evalu-
ate the effect of the extraneous prognostic factors should allow
a more precise estimate of the probability of developing ESRD
for an individual with APKD.
In summary, these data indicate that persons with ultrasono-
graphically detectable APKD may be advised that, conserva-
tively, their chances of developing ESRD before age 40 years
are about 2%, rising to 23% by age 50 years, and 48% by age
73 years.
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